Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • Where available, please put the PMID, PMCID or DOI numbers in the references.
  • Submit a Blinded copy of the article by removing the author name and institution.
    If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Author Guidelines

JSSN is a multi-disciplinary, open-access, peer-reviewed, biannually published scientific journal.

JSSN adheres to the policy published by International Committee of Medical Journal Editors (ICMJE) and to publishing ethics guidelines published by the Committee on Publication Ethics (COPE).

JSSN accepts original research papers, review articles, case reports, surgical education, letter to the editor related to General Surgery and any Subspecialty that are not published or not being considered for publication elsewhere. Authors will be asked to confirm that this is the case during the submission process. Any attempt at dual publication will lead to automatic rejection, may prejudice acceptance of future submissions. However, JSSN accepts papers based on a previous communication to a society or conference or a paper based on thesis work. This has to be disclosed during submission process whether the paper is based on a previous communication to a society or meeting or thesis work.

Editorial Process
Our aim is to provide all authors with a supportive, efficient, productive and quick editorial process.

Submitted manuscript will be first accessed for scope of journal, completeness, language, ethical and legal issues. If found appropriate for consideration it will be sent for external peer review.

Two independent external expert reviewers will review the manuscript individually for scientific and technical basis of the work.

Based upon the reviews received from the peer reviewers the paper may be accepted without changes, accepted with minor or major revisions or rejected with or without possibility of resubmission. However, independent from the comment received from peer reviewer final decision regarding the acceptance and rejection will be made by editorial board.

Authorship
JSSN adheres to the policy published and regularly updated by International Committee of Medical Journal Editors (ICMJE).For detailed and updated information please visit - http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

All authors should meet all four following criteria for authorship, and all who meet the four criteria should be identified as authors.

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  2. Drafting the work or revising it critically for important intellectual content; AND
  3. Final approval of the version to be published; AND
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

The individuals who had contributed to the study but do not meet all the above four criteria of authorship should be acknowledged in acknowledgement section.

The corresponding author has to confirm how all individuals listed as authors meet the appropriate authorship criteria, that no-one who qualifies for authorship has been omitted from the list, that written authorization has been received from all co-authors, that contributors and all funding sources (for authors and contributors) have been properly acknowledged and that authors and contributors have approved the acknowledgement of their contribution.

The corresponding author is responsible for ensuring that all authors have seen, approved and are fully conversant with the contents of the manuscript. All authors are responsible for the accuracy of the manuscript, including all statistical calculations and drug doses.

License to Publish:
Submission of manuscript to JSSN endows JSSN the right to publish it in print and online format.

Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

JSSN applies the Creative Commons Attribution (CC BY) license to all works we publish. Under the CC BY license, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, distribute, and/or copy articles in JSSN, so long as the original authors and source are cited. No permission is required from the authors or the publishers.

Creative Commons License
Articles in JSSN are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Publication Fee
At present JSSN does not charge a publication fee to the authors.

Submission Documents
The manuscript should be submitted along with following documents

  1. Cover Letter - Explaining why the manuscript is suitable for publication in JSSN. Address the following questions: Why will your paper inspire researchers or clinicians, and how will it improve patient care, or drive the understanding of disease forward?
  2. Authorship
  3. Declaration
  4. Manuscript
  5. Approval Letter from Institutional of National Review Board (All research involving humans and animals must have been approved by the authors' institutional review board or equivalent committee(s), and that board must be named by the authors in the manuscript. For research involving human participants, informed consent must have been obtained or the reason for lack of consent explained, and all clinical investigations must have been conducted according to the principles expressed in the "Declaration of Helsinki". The Methods section of the paper must state about the approval from the board and informed consent)

Submission guidelines
The files should be submitted in .doc or .docs format. Files submitted in .pdf, .zip, .com will not be accepted.

Arial font size 12 should be used in manuscript. Texts should be typed in double space, margin 25 mm and page number should begin from title page bottom right side.

When starting a sentence with a number, please spell the number. For e.g. “Seventy one percent of subjects had...”

Single digit numbers should be spelled out. For e.g. “..was found in two percent..”.

When using drug names, generic names should be used. Trade names are not allowed.

Please do not write in contractions. For e.g. write “do not” instead of “don’t”.

A brief overview of the writing process for the manuscript is given below. Authors are advised to download the templates of individual manuscript (link to templates)

a) Title page
On the title page please state: (1) the title of the article; (2) the name and initials of each author; (3) the department(s) and institution(s) to which the work should be attributed; (4) the name, postal and e-mail addresses, telephone and facsimile numbers of the author responsible for correspondence and to whom requests for reprints should be addressed; (5) sources of funding for research and/or publication; (6) the category in which the manuscript is being submitted (original article, review, randomized clinical trial); and (7) whether the paper is based on a previous communication to a society or meeting (with full details).

b) Abstract with keywords
Abstract must contain be in a structured format. Introduction: state why the study was done, the main aim and the nature of the study (randomized clinical trial, retrospective review, experimental study, etc.). Methods: describe patients, laboratory material and other methods used. Results: state the main findings, including important numerical values. Conclusion: state the main conclusions, highlighting controversial or unexpected observations.

Keywords: Provide 3 to 6 keywords in alphabetical orders separated buy semicolons. Use words listed in MeSH index.

c) Main Body
Main body of the paper should have separate Introduction, Methods, Results and Discussion sections (these sections may not be applicable to all article types, e.g. Reviews).

d) Illustrations and Tables
Images: All images should be in greyscale.

Caption and Numbering: All images must be numbered as: Figure “number (in Arabic numerals)” with a title describing the image, placed below the image. The caption should read like “Figure 1: Figure title”.  The captions should be placed where the image is meant to be in the manuscript with one line spacing above and below the caption. 

Graphs/Charts: Caption and numbering: same as Images. If possible, please send us the graphs/charts as part of Microsoft Worksheet along with the data used to generate the graph/chart.

  • Units of measurements should be in SI units (International system of units) as far as possible.
  • Submit each illustration as a separate file except compound figures e.g. 1a, 1b, 1c, etc., which should be supplied as a single file.

Tables: Title of table should be placed above the table. The title should read like "Table 1: Table title". Table may be placed within the text of manuscript or attached as a separate file. In the latter case, the title of the table should be placed where the table is meant to be placed with a line spacing above and below the title.

e) Abbreviations
Avoid using abbreviations. Terms that are mentioned frequently may be abbreviated but only if this does not impair comprehension. Abbreviations must be used consistently and must be defined on first use.

f) Numbers and units
Provide absolute numbers always; percentages may be given in addition but never on their own (percentages are not acceptable for sample sizes less than 50). Use SI units (International System of Units) as far as possible.</>

g) Statistics and design
Objectives of the study should be clearly defined. The primary and secondary hypotheses with end points must be clear.

Clearly describe methods used for analysis; methods not in common usage should be referenced. Report results of statistical tests by stating the value of the test statistic, the number of degrees of freedom and the P value. Actual P values should always be reported to three decimal places, especially when the result is not significant. The results of the primary analyses should be reported using confidence intervals instead of, or in addition to, P values.

h) References
JSSN follows modified Vancouver system as devised in the NLM style guide for authors, editors, and publishers for referencing, which is available as a book: “Citing Medicine, 2nd edition”. The book can be downloaded free of cost at: http://www.nlm.nih.gov/citingmedicine and NLM quick reference can be found at http://www.wsulibs.wsu.edu/quickguides/nlm.

NLM Style Tips: NLM style has no bolding, italics, or underlines in the reference list. Journal titles should be abbreviated.  If you're unsure of the official abbreviation, check your source in PubMed or search for the publication name here. Cite what you saw. If you used an online journal article, use the format for an online journal article.  If you used a print article, use the format for print article. No hanging indent is requiredStart your reference list on a new page with the heading "references," "cited references," or "bibliography." List first six authors on each reference, if there are more than six authors mention et al following first six authors.

In the text citation
Citation is done in form of Arabic numbers that correlates with the source in the reference list at the end of the document.

Following points illustrate the style JSSN follows for citing sources:

  1. A number is allocated to a source in the order in which it first appears in the text. If the source is referred to again, the same number is used.
  2. Citation numbers are placed in superscript format. No parenthesis is used.
  3. The numbers are placed to the right of colons and semi-colons. Similarly they are placed after full-stops.
  4. When multiple references are cited together, the numbers are separated by a comma. In case of more than two consecutive numbers, first and last numbers are separated by hyphen.

E.g. Similar results have been obtained in various studies.4-7, 15

You need to give a reference even when the author's name is stated in the sentence or in table.

If you refer to a source more than once, you should use the same number you used the first time you referred to that particular source.

References cited only in tables or figures should be numbered in sequence.

We encourage authors to use a computerized bibliographic program. For e.g. Mendeley, Endnote, Zotero etc.

We encourage authors to follow the reporting guidelines for different study designs. For e.g. CONSORT (www.consort -statement.org) for randomized trials, STROBE for observational studies (http://strobe-statement.org/), PRISMA for systematic reviews and meta-analyses (http://prisma -statement.org/), and STARD for studies of diagnostic accuracy (www.stard-statement.org/).  Authors of review manuscripts should describe the methods used for locating, selecting, extracting, and synthesizing data; this is mandatory for systematic reviews. Good sources for reporting guidelines are the EQUATOR Network (www.equator-network.org/home/) and the NLM’s Research Reporting Guidelines and Initiatives (www.nlm.nih.gov/services/research_report_guide.html).

Guidelines for individual manuscript

Original Article
JSSN accepts original researches conducted in the field of General Surgery, Surgical Subspecialty, Surgical education, Basic science relevant to surgical practice, Surgical Critical Care.

Original articles should normally be in the format of Introduction, Methods, Results and Discussion and should have maximum of 3500 words with a structured abstract of less than 250 words should be provided.

JSSN request all authors to register prospective clinical trials in a suitable electronic and freely accessible registry (e.g. www.clinicaltrials.gov, www.controlled-trials.com), according to the ICMJE guidelines.

It should be written under the following headings: 1. Title and authorship 2. Abstract 3. Introduction 4. Methods 5. Results 6. Discussion 7. Acknowledgement 8.  References.

Review Article (including systematic reviews and meta-analyses)
Review articles are which summarize the current state of understanding on a topic and analyzes or discuss research previously published by others, rather than reporting new experimental results.

They are very thorough literature reviews that identify historical and current trends in the research, important scholars in the field, foundational articles, major discoveries, gaps in the research (areas for further exploration), and current debates or controversies.

A review article should have maximum of 3000 words excluding abstract which should be of maximum 250 words and references (>50 and <100). It should be written under the following headings: 1. Title and authorship 2. Abstract 3. Introduction 4. Body 5. Discussion 6. Acknowledgement 7. References.

Case Reports
JSSN accepts case reports with literature review that includes, a rare case, an unexpected association between diseases or symptoms, an unexpected event in the course of treatment such as complications and other adverse events that are significant enough to share among scientific committee.

A case report should have maximum of 1000 words excluding abstract which should be of maximum 100 words and references (up to 10). A case report should be written in following sections: 1. Title with Author Information 2. Abstract with key words 3. Introduction 4. Case Report 5. Discussion 6. Acknowledgement 7. References.

Surgical Education
JSSN accepts perspective on undergraduate, postgraduate and continuing surgical education. The issues of training in surgery including curriculum development and reforms, innovation in surgical education, training and assessment are accepted with word limit up to 1500 words excluding abstract of 150 words.

Letter to the Editor
Critique/respond to a specific article that the journal has recently published. Letter must be timely and must be concise. It should be a thought provoking commentary of less than 1000 words without abstract and 1 table or figure with maximum of 5-10 references.

Copyright Notice

Copyright and Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

JSSN applies the Creative Commons Attribution (CC BY) license to all works we publish. Under the CC BY license, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, distribute, and/or copy articles in JSSN, so long as the original authors and source are cited. No permission is required from the authors or the publishers.

Article by JSSN is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://www.jssn.org.np/index.php?journal=jssn.

Privacy Statement

Nepal Journals Online (NepJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, NepJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to NepJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)